Literature DB >> 17438058

Prophylactic effect of dietary seaweed Fucoidan against enteral prion infection.

Katsumi Doh-Ura1, Tomoko Kuge, Miyuki Uomoto, Keiko Nishizawa, Yuri Kawasaki, Masahiko Iha.   

Abstract

Dietary seaweed fucoidan delays the onset of disease of enterally infected mice with scrapie when given orally for 6 days after infection, but not when given before the infection. This effect was not modified at a tested fucoidan dose range and appeared to reach the maximum level at a concentration of 2.5% or less in feed. Daily uptake of fucoidan might be prophylactic against prion diseases caused by ingestion of prion-contaminated materials, although further evaluation of its pharmacology remains to be done.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438058      PMCID: PMC1891374          DOI: 10.1128/AAC.00917-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide.

Authors:  Olivier Berteau; Barbara Mulloy
Journal:  Glycobiology       Date:  2003-03-06       Impact factor: 4.313

2.  Structural study of fucoidan from Cladosiphon okamuranus TOKIDA.

Authors:  M Nagaoka; H Shibata; I Kimura-Takagi; S Hashimoto; K Kimura; T Makino; R Aiyama; S Ueyama; T Yokokura
Journal:  Glycoconj J       Date:  1999-01       Impact factor: 2.916

3.  Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine.

Authors:  Katsumi Doh-ura; Kazuhiko Tamura; Yoshiharu Karube; Mikihiko Naito; Takashi Tsuruo; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2007-01-19       Impact factor: 5.046

4.  Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models.

Authors:  Katsumi Doh-ura; Kensuke Ishikawa; Ikuko Murakami-Kubo; Kensuke Sasaki; Shirou Mohri; Richard Race; Toru Iwaki
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  A novel generation of heparan sulfate mimetics for the treatment of prion diseases.

Authors:  Karim Tarik Adjou; Steve Simoneau; Nicole Salès; François Lamoury; Dominique Dormont; Dulce Papy-Garcia; Denis Barritault; Jean-Philippe Deslys; Corinne Ida Lasmézas
Journal:  J Gen Virol       Date:  2003-09       Impact factor: 3.891

Review 6.  Prion diseases--close to effective therapy?

Authors:  Neil R Cashman; Byron Caughey
Journal:  Nat Rev Drug Discov       Date:  2004-10       Impact factor: 84.694

7.  Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis.

Authors:  Oshrat Schonberger; Lior Horonchik; Ruth Gabizon; Dulce Papy-Garcia; Denis Barritault; Albert Taraboulos
Journal:  Biochem Biophys Res Commun       Date:  2003-12-12       Impact factor: 3.575

Review 8.  Current perspectives on bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease.

Authors:  D M Taylor
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

9.  Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected].

Authors:  B Caughey; K Brown; G J Raymond; G E Katzenstein; W Thresher
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent.

Authors:  R E Race; S A Priola; R A Bessen; D Ernst; J Dockter; G F Rall; L Mucke; B Chesebro; M B Oldstone
Journal:  Neuron       Date:  1995-11       Impact factor: 17.173

View more
  10 in total

1.  Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner.

Authors:  Yuri Kawasaki; Keiichi Kawagoe; Chun-jen Chen; Kenta Teruya; Yuji Sakasegawa; Katsumi Doh-ura
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

2.  Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.

Authors:  Taichi Hamanaka; Keiko Nishizawa; Yuji Sakasegawa; Ayumi Oguma; Kenta Teruya; Hiroshi Kurahashi; Hideyuki Hara; Suehiro Sakaguchi; Katsumi Doh-Ura
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

3.  Assessment of prospective preventive therapies for chronic wasting disease in mule deer.

Authors:  Lisa L Wolfe; David A Kocisko; Byron Caughey; Michael W Miller
Journal:  J Wildl Dis       Date:  2012-04       Impact factor: 1.535

4.  In vitro anti-canine distemper virus activity of fucoidan extracted from the brown alga Cladosiphon okamuranus.

Authors:  Laura M Trejo-Avila; Maria Elena Morales-Martínez; Denis Ricque-Marie; L Elizabeth Cruz-Suarez; Pablo Zapata-Benavides; Karla Morán-Santibañez; Cristina Rodríguez-Padilla
Journal:  Virusdisease       Date:  2014-10-01

Review 5.  Therapeutic development of polymers for prion disease.

Authors:  Kenta Teruya; Katsumi Doh-Ura
Journal:  Cell Tissue Res       Date:  2022-03-21       Impact factor: 5.249

Review 6.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

Review 7.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

8.  A Medicinal Herb Scutellaria lateriflora Inhibits PrP Replication in vitro and Delays the Onset of Prion Disease in Mice.

Authors:  Martin Eiden; Fabienne Leidel; Barbara Strohmeier; Christine Fast; Martin H Groschup
Journal:  Front Psychiatry       Date:  2012-02-17       Impact factor: 4.157

9.  Anti-prion activity found in beetle grub hemolymph of Trypoxylus dichotomus septentrionalis.

Authors:  Taichi Hamanaka; Keiko Nishizawa; Yuji Sakasegawa; Hiroshi Kurahashi; Ayumi Oguma; Kenta Teruya; Katsumi Doh-Ura
Journal:  Biochem Biophys Rep       Date:  2015-07-17

Review 10.  Fucoidan: structure and bioactivity.

Authors:  Bo Li; Fei Lu; Xinjun Wei; Ruixiang Zhao
Journal:  Molecules       Date:  2008-08-12       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.